InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Wednesday, 11/25/2015 11:45:37 AM

Wednesday, November 25, 2015 11:45:37 AM

Post# of 118384
To expect RGBP at this point to run to $15 on FDA approval of clinical trials is fantasy in my opinion.

If the FDA approval mentioned was outright FDA approval of the drug itself and not just clinical trials, then we could speculate on such a reaction to the stock PPS. But to say RGBP is going to run to 15 from .15 on FDA approval of clinical trials is pure fantasy land and no one else with any credibility should be supporting such a claim. Many small cap companies with products in later stages of development trade under $2.

If RGBP runs to even $1 on FDA approval of HemaX clinical trials I'll be happy and then if it runs to $2 on Orphan Status approval which is to follow, that would be very good. If that is accompanied by other significant developments, it might push higher, but let's not get caught up in $15 value with over 100 million shares issued.

Please. AIMO

~ RGBP = Expect a Run like KBIO..in..RGBP!! wink

In Comparison,, KBIO went from around the .442 area to $10 in just a Few Minutes!! wink
...and then on up to $45.82 in a couple days after that!! = a 10,266% Increase!!! wink

RGBP on 1st FDA Approval going up 10,000% from .15 = $15 !! wink

RGBP on 2st FDA Approval going up 20,000% from .15 = $30 !! wink

BUT = INVESTORS HAVE TO OWN IT IN ORDER TO WIN $$ IN RGBP's POP~UP!!! wink

Like I stated several weeks ago,, RGBP will POP well over $8+ in just a few minutes,, and it will be Faster then an Investor can even Type in an Order to Buy...LMFAO!! wink